Science Explorer Back to mapMap
Discussion
Researcher · Nanchong Central Hospital · China

Jun Bie

Jun Bie publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as CAR-T cell therapy research, Inflammatory Biomarkers in Disease Prognosis and Cancer Research and Treatments.

ORCID 0000-0002-8296-0544 OpenAlex
World rank
#4,110,064
of 7,710,434 ranked researchers
Rank in China
#636,569
of 978,568
Works
51
Citations
1.1k
Citations per work
21.1
h-index
8
i10-index 7Top 72% in Oncology
Jun Bie

What does Jun Bie research?

Jun Bie's work is mostly in Medicine (40%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (7%).

Health Sciences: 20 works · 39.6% of their workMedicine: 20 works · 39.6% of their workOncology: 12 works · 24.0% of their workPulmonary and Respiratory Medicine: 5 works · 9.1% of their workSurgery: 3 works · 6.5% of their workEverything else: 18 works · 35.8% of their workLife Sciences: 13 works · 24.6% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 17.5% of their workMolecular Biology: 6 works · 11.7% of their workCancer Research: 3 works · 5.8% of their workImmunology and Microbiology: 4 works · 7.1% of their workImmunology: 4 works · 7.1% of their workTHEIR WORKJun Bie51works
Life Sciences25%Health Sciences40%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2039.6%
  2. Everything else1835.8%
    1. Biochemistry, Genetics and Molecular Biology917.5%
    2. Immunology and Microbiology47.1%
  1. 1Oncology24% of their works
  2. 2Molecular Biology12% of their works
  3. 3Pulmonary and Respiratory Medicine9% of their works
  4. 4Immunology7% of their works
  5. 5Surgery6% of their works
  6. 6Cancer Research6% of their works

Research topics

Which keywords describe Jun Bie's research?

The keywords of their largest research topics: Immunotherapy, Tumor Microenvironment, Tumor Regression, Cancer, CAR T Cells, Chimeric Antigen Receptor, Immunity and Inflammation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Immunotherapy112 topics
  2. Tumor Microenvironment112 topics
  3. Tumor Regression112 topics
  4. Cancer102 topics
  5. CAR T Cells61 topic
  6. Chimeric Antigen Receptor61 topic
  7. Immunity61 topic
  8. Inflammation61 topic
  9. Bacterial Therapy51 topic
  10. Esophageal Carcinoma51 topic
  11. Immune Checkpoint Blockade51 topic
  12. PD-1 and PD-L151 topic
  13. Preoperative Chemoradiotherapy51 topic
  14. Tumor Targeting51 topic
  15. Antimicrobial Agents41 topic
  16. Cancer Stem Cells41 topic
  17. Febrile Neutropenia41 topic
  18. RNA methylation41 topic
  19. Tumor Metastasis41 topic
  20. m6A-seq41 topic

Where does Jun Bie work?

Jun Bie's main affiliation in the publication record is Nanchong Central Hospital, China.

How many publications and citations does Jun Bie have?

OpenAlex counts 51 works and 1,078 citations for Jun Bie, an h-index of 8, ranking #4,110,064 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jun Bie. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.